InvestorsHub Logo

Boxsterfan

02/26/14 11:23 AM

#3111 RE: MasterJ #3110

ALXA is simply preparing to dilute. They have no cash for advancing any pipeline drugs.

There are only two realistic ways they do NOT dilute:

1. Adasuve sales are so stupendous out the gate that cash is rolling in hand over fist.

2. Anoher biotech company partners with them and funds the next pipeline drug.

Dilution is inevitable here.

Scifi1

02/26/14 11:33 AM

#3112 RE: MasterJ #3110

Yes it has been a quiet run up, along with a quite (soft) launch by TEVA. Nothing spectacular on any given day just "below the radar" activity. I'm cautiously encouraged.